Skip to main content
Clinical Trials/JPRN-UMIN000009329
JPRN-UMIN000009329CompletedPhase 2

Study of Clinical Usefulness of 18F-fluorothymidine(FLT) PET/CT in Ditection of Peritoneal Metastases of Gastric Cancer - Study of Usefulness of 18F-FLT PET/CT in Peritoneal Metastases of Gastric Cancer

Department of Gastrointestinal Oncology, National Cancer Center Hospital in Japan0 sites40 target enrollmentStarted: November 13, 2012Last updated:

Trial Snapshot

Phase
Phase 2
Status
Completed
Sponsor
Enrollment
40

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
20years-old to ot applicable (—)
Sex
All

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1.Peritoneal metastases detected only by cytology of ascites. 2.Patients who have alcoholic hyper- sensitivity. 3.Patients with active infection. 4.Pregnant women or women who have the possibility to be pregnant or lactating woman. 5.Patients who are considered to be ineligible by referring physician.

Investigators

Sponsor
Department of Gastrointestinal Oncology, National Cancer Center Hospital in Japan

Similar Trials